GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials
Based on a large number of patients who contributed to a meta-analysis of RCTs involving participants with type 2 diabetes and cardiometabolic disease, GLP-1 RAs were not associated with an increased risk of optic nerve/vision-threatening events.
Authors
- Hoi-Ying Li
- Kai-Hang Yiu (ORCID: https://orcid.org/0000-0003-2145-3108)
- B My Cheung
- Hung-Fat Tse
- Tsz-Kwan Chan
- Kendrick Co Shih
- Yap-Hang Chan
Institutions
- University of Cambridge (GB)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-01-26
- DOI
- https://doi.org/10.2337/dc25-1929
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00